RareCyte: David Kabakoff, Andy Schwab

In conjunction with RareCyte's recent financing round, David Kabakoff and Andy Schwab have joined the company's board of directors. Kabakoff is a partner at HealthQuest Capital and Schwab is a managing partner at 5AM Ventures. Both companies are RareCyte investors.